SLNO News and Press, Soleno Therapeutics Inc. From 03/07/24

2024-03-07 10:01:04 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Waters, Moderna most shorted ...

2024-03-06 16:47:28 ET More on Soleno Therapeutics Soleno Therapeutics And Acadia Pharmaceuticals: Hope For Prader-Willi Families Seeking Alpha’s Quant Rating on Soleno Therapeutics Historical earnings data for Soleno Therapeutics Financial information...

REDWOOD CITY, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided a corporate update, and reported financial results for the fourth...

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is the focus of IBN's latest stock spotlight. The company's shares have moved 2.83% on the day to $48.66. Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for t...

REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., Chief Executive Offic...

2024-01-22 22:42:14 ET Summary ACADIA Pharmaceuticals and Soleno Therapeutics are both conducting late-stage trials for the treatment of Prader-Willi Syndrome. PWS is a rare disease characterized by various physical and developmental challenges. Acadia is an established commer...

2024-01-22 11:54:46 ET More on highly-shorted stocks Spirit Airlines: Don't Join The Panic Spirit Airlines: Ch.11 Bankruptcy Could Be A Better Option To Save The Airline Assessing JetBlue Airways During A Time Of Significant Uncertainty Over Spirit Airlines Turmoil ...

2024-01-17 15:09:43 ET More on crowded shorts VinFast's Warm Reception In Contrast To Cold Shoulder Chinese EV Makers Are Getting ImmunityBio: Approval Likely Priced In, Yielding Mostly Risk For Would-Be Buyers Beyond Meat: No Path To Recovery VinFast Auto la...

2024-01-11 13:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Shares of Soleno Therapeutics, Inc. (NASDAQ: SLNO) traded at a new 52-week high today and are currently trading at $23.03. So far today, approximately 140.58k shares have been exchanged, as compared to an average 30-day volume of 383.77k shares. Soleno Therapeutics, Inc., a clinical-stage bio...